Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  RedHill Biopharma Ltd    RDHL   IL0011223810

REDHILL BIOPHARMA LTD (RDHL)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 12/13 04:24:26 pm
261.4 ILa   -0.23%
 SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
12/09/2018 12/10/2018 12/11/2018 12/12/2018 12/13/2018 Date
260(c) 262.2(c) 267.7(c) 262(c) 260.9(c) Last
406 254 240 816 251 830 146 195 66 679 Volume
-1.52% +0.85% +2.10% -2.13% -0.42% Change
More quotes
Financials (USD)
Sales 2018 12,4 M
EBIT 2018 -39,2 M
Net income 2018 -39,2 M
Finance 2018 1,03 M
Yield 2018 -
Sales 2019 30,2 M
EBIT 2019 -36,7 M
Net income 2019 -36,7 M
Debt 2019 11,0 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 15,7x
EV / Sales2019 6,84x
Capitalization 196 M
More Financials
Company
Redhill Biopharma Ltd, is an Israel-based specialty biopharmaceutical company. The Company focuses on the development and commercialization of late clinical-stage, proprietary, orally-administered, small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer. It... 
More about the company
Latest news on REDHILL BIOPHARMA LTD
12/11RedHill Biopharma Announces Closing of $20 Million Underwritten Offering
GL
12/06RedHill Biopharma Announces Pricing of $20 Million Underwritten Offering
GL
12/04RedHill Biopharma Announces Proposed Public Offering of its American Deposita..
GL
12/04REDHILL BIOPHARMA : Announces Positive Top-Line Results from Confirmatory Phase ..
AQ
12/04REDHILL BIOPHARMA : Announces Positive Top-Line Results from Confirmatory Phase ..
AQ
12/03REDHILL BIOPHARMA : Israel’s RedHill says drug shown effective in eradicat..
AQ
12/03RedHill Biopharma Announces Positive Top-Line Results from Confirmatory Phase..
GL
11/30REDHILL BIOPHARMA : to Present at BMO 2018 Prescriptions for Success Healthcare ..
AQ
11/29RedHill Biopharma to Present at BMO 2018 Prescriptions for Success Healthcare..
GL
11/15REDHILL BIOPHARMA : Announces Presentation on YELIVA (opaganib) for Multiple Mye..
AQ
More news
Sector news : Bio Therapeutic Drugs
12/13Lilly, Incyte Get FDA Fast-Track Designation for Baricitinib in Systemic Lupu..
DJ
12/10Almost half of S&P 500 stocks in a bear market
RE
12/10ROCHE : Gilead Sciences snares Roche veteran O'Day as CEO
RE
12/10LONZA : to Establish Biomanufacturing Base in China
DJ
12/10Roche Pharmaceuticals Names New CEO as O'Day Leaves to Head Gilead -- Update
DJ
More sector news : Bio Therapeutic Drugs
Chart REDHILL BIOPHARMA LTD
Duration : Period :
RedHill Biopharma Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REDHILL BIOPHARMA LTD
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
EPS Revisions
Managers
NameTitle
Dror Ben-Asher Chairman & Chief Executive Officer
Gilead Raday Chief Operating Officer
Micha Ben-Chorin Chief Financial Officer
Reza Fathi Senior Vice President-Research & Development
Ira N. Kalfus Medical Director
Sector and Competitors
1st jan.Capitalization (M$)
REDHILL BIOPHARMA LTD48.83%196
GILEAD SCIENCES-5.99%87 125
VERTEX PHARMACEUTICALS17.08%44 319
REGENERON PHARMACEUTICALS0.68%40 244
GENMAB3.74%9 984
SAREPTA THERAPEUTICS INC119.30%8 154